The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer-Reference-Cited by-同舟云学术

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

Published:2015-06 Issue:4 Volume:18 Page:541-546
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Garrison Louis P.,Babigumira Joseph B.,Masaquel Anthony,Wang Bruce C.M.,Lalla Deepa,Brammer Melissa

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference32 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. HER-2 testing in breast cancer using parallel tissue-based methods;Yaziji;JAMA,2004

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

5. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine;Ross;Oncologist,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Proteomics for Solid Organ Tissues;Molecular & Cellular Proteomics;2023-11

2. Conclusion;GDPR Requirements for Biobanking Activities Across Europe;2023

3. Hashing-based Undersampling for Large Scale Histopathology Image Classification;2022 IEEE 21st International Conference on Cognitive Informatics & Cognitive Computing (ICCI*CC);2022-12-08

4. Evaluation of ER, PR and HER2 markers by flow cytometry for breast cancer diagnosis and prognosis;Clinica Chimica Acta;2021-12

5. HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device;Cancers;2021-09-03